• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Understanding Kratom Use: A Guide for Healthcare Providers.了解 kratom 的使用:医疗保健提供者指南。
Front Pharmacol. 2022 Mar 2;13:801855. doi: 10.3389/fphar.2022.801855. eCollection 2022.
2
Exploring the self-reported motivations of kratom ( Korth.) use: a cross-sectional investigation.探索 kratom(Korth.)使用的自我报告动机:一项横断面调查。
Am J Drug Alcohol Abuse. 2022 Jul 4;48(4):433-444. doi: 10.1080/00952990.2022.2041026. Epub 2022 Apr 7.
3
The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.kratom的药理学与毒理学:从传统草药到滥用药物
Int J Legal Med. 2016 Jan;130(1):127-38. doi: 10.1007/s00414-015-1279-y. Epub 2015 Oct 28.
4
Evaluating health information provided to kratom consumers by good manufacturing practice-qualified vendors.评估符合良好生产规范资质的供应商向卡痛消费者提供的健康信息。
Subst Abuse Treat Prev Policy. 2023 Apr 11;18(1):21. doi: 10.1186/s13011-023-00531-4.
5
Kratom: The safe legal high?kratom:安全的合法兴奋剂?
Epilepsy Behav. 2021 Apr;117:107882. doi: 10.1016/j.yebeh.2021.107882. Epub 2021 Mar 6.
6
Kratom use and mental health: A systematic review.使用咔特(Kratom)与心理健康:系统性回顾。
Drug Alcohol Depend. 2018 Feb 1;183:134-140. doi: 10.1016/j.drugalcdep.2017.10.012. Epub 2017 Dec 7.
7
Kratom: Implications for Health Care Providers.kratom:对医疗保健提供者的影响。
J Psychosoc Nurs Ment Health Serv. 2019 Dec 1;57(12):15-20. doi: 10.3928/02793695-20191112-03.
8
Current perspectives on the impact of Kratom use.关于使用 kratom 的影响的当前观点。
Subst Abuse Rehabil. 2019 Jul 1;10:23-31. doi: 10.2147/SAR.S164261. eCollection 2019.
9
The Adverse Cardiovascular Effects and Cardiotoxicity of Kratom ( Korth.): A Comprehensive Review.kratom(Korth.)的心血管不良影响和心脏毒性:综述
Front Pharmacol. 2021 Sep 27;12:726003. doi: 10.3389/fphar.2021.726003. eCollection 2021.
10
Kratom as a potential substance use disorder harm reduction agent.Kratom 作为一种潜在的物质使用障碍减少伤害的药物。
Front Public Health. 2024 May 30;12:1416689. doi: 10.3389/fpubh.2024.1416689. eCollection 2024.

引用本文的文献

1
Evaluating the drug interactions in kratom usage: clinical application.评估 kratom 使用中的药物相互作用:临床应用
Expert Opin Drug Metab Toxicol. 2025 Jun 22:1-11. doi: 10.1080/17425255.2025.2521045.
2
An exploratory study of the safety profile and neurocognitive function after single doses of mitragynine in humans.单次给予人米托蒽醌后安全性概况及神经认知功能的探索性研究。 (注:原文中药物名称可能有误,正确的应该是米托坦“mitotane”,这里按照你提供的“mitragynine”翻译)
Psychopharmacology (Berl). 2025 Jun;242(6):1363-1376. doi: 10.1007/s00213-024-06734-2. Epub 2024 Dec 26.
3
Quantification of 11 kratom alkaloids including mitragynine and its main metabolites in human plasma using LC-MS/MS.使用液相色谱-串联质谱法对人血浆中包括帽柱木碱及其主要代谢物在内的11种 kratom 生物碱进行定量分析。
Anal Bioanal Chem. 2025 Feb;417(4):761-769. doi: 10.1007/s00216-024-05689-9. Epub 2024 Dec 7.
4
Kratom (Mitragyna speciosa) use for self-management of pain: Insights from cross-sectional and ecological momentary assessment data.用于疼痛自我管理的 kratom(帽柱木属):来自横断面和生态瞬时评估数据的见解。
J Pain. 2025 Jan;26:104726. doi: 10.1016/j.jpain.2024.104726. Epub 2024 Nov 4.
5
Kratom safety and toxicology in the public health context: research needs to better inform regulation.公共卫生背景下的 kratom 安全性与毒理学:需要开展研究以更好地为监管提供依据。
Front Pharmacol. 2024 Jun 3;15:1403140. doi: 10.3389/fphar.2024.1403140. eCollection 2024.
6
Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency.根据 DSM-5 SUD 标准,阿片类药物使用障碍与阿片类药物躯体依赖:剂量与频率的影响。
Drug Alcohol Depend. 2024 Jul 1;260:111329. doi: 10.1016/j.drugalcdep.2024.111329. Epub 2024 May 20.
7
Description of Kratom Exposure Events in Wisconsin as Reported to the Wisconsin Poison Center, January 1, 2010 to September 1, 2022.描述 2010 年 1 月 1 日至 2022 年 9 月 1 日期间向威斯康星州毒物控制中心报告的有关 Kratom 暴露事件。
WMJ. 2023 Jul;122(3):187-190.
8
Kratom withdrawal: Discussions and conclusions of a scientific expert forum.kratom戒断反应:一个科学专家论坛的讨论与结论
Drug Alcohol Depend Rep. 2023 Mar 15;7:100142. doi: 10.1016/j.dadr.2023.100142. eCollection 2023 Jun.
9
Cannabinoid mechanisms contribute to the therapeutic efficacy of the kratom alkaloid mitragynine against neuropathic, but not inflammatory pain.大麻素机制有助于治疗功效的东革阿里生物碱 mitragynine 对神经性疼痛,但不是炎性疼痛。
Life Sci. 2023 Sep 1;328:121878. doi: 10.1016/j.lfs.2023.121878. Epub 2023 Jun 29.
10
Kratom use disorder and unfolded protein response: Evaluating their relationship in a case control study.阿片类物质使用障碍与未折叠蛋白反应:病例对照研究评估两者的关系。
PLoS One. 2023 Jun 23;18(6):e0287466. doi: 10.1371/journal.pone.0287466. eCollection 2023.

本文引用的文献

1
Kratom Abuse Potential 2021: An Updated Eight Factor Analysis.2021年 kratom 的滥用可能性:最新的八因素分析
Front Pharmacol. 2022 Jan 28;12:775073. doi: 10.3389/fphar.2021.775073. eCollection 2021.
2
Social, psychological, and substance use characteristics of U.S. adults who use kratom: Initial findings from an online, crowdsourced study.美国使用咔特的成年人的社会、心理和物质使用特征:一项在线众包研究的初步发现。
Exp Clin Psychopharmacol. 2022 Dec;30(6):983-996. doi: 10.1037/pha0000518. Epub 2021 Nov 4.
3
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use.有警示的治疗益处?:分析社交媒体数据以了解使用卡痛的复杂性。
Drug Alcohol Depend. 2021 Sep 1;226:108879. doi: 10.1016/j.drugalcdep.2021.108879. Epub 2021 Jun 25.
4
The Use of Kratom (Mitragyna speciosa Korth.) Among People Who Co-use Heroin and Methamphetamine in Malaysia.马来西亚海洛因和甲基苯丙胺共同使用者中对 kratom(帽柱木属 )的使用情况
J Addict Med. 2022;16(2):223-228. doi: 10.1097/ADM.0000000000000876.
5
When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use.当一种模糊变得流行时:社交媒体对曲坦丁使用情况的描述以及相关的非典型药物使用情况。
Am J Drug Alcohol Abuse. 2021 Jul 4;47(4):455-466. doi: 10.1080/00952990.2021.1904408. Epub 2021 Apr 28.
6
Oral Pharmacokinetics in Beagle Dogs of the Mitragynine Metabolite, 7-Hydroxymitragynine.在比格犬中代谢产物 7-羟基帽柱木碱的口服药代动力学。
Eur J Drug Metab Pharmacokinet. 2021 May;46(3):459-463. doi: 10.1007/s13318-021-00684-2. Epub 2021 Apr 13.
7
Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats.口服传统或商业咔哇产品后 11 种咔哇生物碱的药代动力学在大鼠体内的研究。
J Nat Prod. 2021 Apr 23;84(4):1104-1112. doi: 10.1021/acs.jnatprod.0c01163. Epub 2021 Feb 23.
8
Effects of Nutrient Fertility on Growth and Alkaloidal Content in (Kratom).营养肥力对( kratom )生长和生物碱含量的影响。
Front Plant Sci. 2020 Dec 21;11:597696. doi: 10.3389/fpls.2020.597696. eCollection 2020.
9
Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for -Opioid Receptor and Opioid-Like Behavioral Effects in Rats.**标题**:**Mitragynine** 和 **7-羟基-Mitragynine** 的药理学比较:体外对 -阿片受体的亲和力和效力以及在大鼠中的类阿片样行为效应。
J Pharmacol Exp Ther. 2021 Mar;376(3):410-427. doi: 10.1124/jpet.120.000189. Epub 2020 Dec 31.
10
Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions.植物化学成分与生物效应:东革阿里(蒺藜科植物)的体外研究与疗效和药物相互作用的关系。
Sci Rep. 2020 Nov 5;10(1):19158. doi: 10.1038/s41598-020-76119-w.

了解 kratom 的使用:医疗保健提供者指南。

Understanding Kratom Use: A Guide for Healthcare Providers.

作者信息

Swogger Marc T, Smith Kirsten E, Garcia-Romeu Albert, Grundmann Oliver, Veltri Charles A, Henningfield Jack E, Busch Lorna Y

机构信息

Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, United States.

Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, United States.

出版信息

Front Pharmacol. 2022 Mar 2;13:801855. doi: 10.3389/fphar.2022.801855. eCollection 2022.

DOI:10.3389/fphar.2022.801855
PMID:35308216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8924421/
Abstract

Kratom ( Korth., Rubiaceae) is a plant native to Southeast Asia, where it has been used for centuries as a mild stimulant and as medicine for various ailments. More recently, as kratom has gained popularity in the West, United States federal agencies have raised concerns over its safety leading to criminalization in some states and cities. Some of these safety concerns have echoed across media and broad-based health websites and, in the absence of clinical trials to test kratom's efficacy and safety, considerable confusion has arisen among healthcare providers. There is, however, a growing literature of peer-reviewed science that can inform healthcare providers so that they are better equipped to discuss kratom use with consumers and people considering kratom use within the context of their overall health and safety, while recognizing that neither kratom nor any of its constituent substances or metabolites have been approved as safe and effective for any disease. An especially important gap in safety-related science is the use of kratom in combination with physiologically active substances and medicines. With these caveats in mind we provide a comprehensive overview of the available science on kratom that has the potential to i clarity for healthcare providers and patients. We conclude by making recommendations for best practices in working with people who use kratom.

摘要

kratom(茜草科,Korth.属)是一种原产于东南亚的植物,在那里它作为一种温和的兴奋剂以及治疗各种疾病的药物已有数百年历史。最近,随着kratom在西方越来越受欢迎,美国联邦机构对其安全性表示担忧,导致在一些州和城市将其定为犯罪。其中一些安全担忧在媒体和广泛的健康网站上得到了回应,并且由于缺乏测试kratom功效和安全性的临床试验,医疗保健提供者之间出现了相当大的困惑。然而,有越来越多经过同行评审的科学文献可以为医疗保健提供者提供信息,使他们能够更好地与消费者以及考虑使用kratom的人讨论在其整体健康和安全背景下使用kratom的问题,同时认识到kratom及其任何成分物质或代谢物都未被批准对任何疾病安全有效。与安全相关的科学中一个特别重要的空白是kratom与生理活性物质和药物联合使用的情况。考虑到这些注意事项,我们对有关kratom的现有科学进行了全面概述,这有可能为医疗保健提供者和患者澄清问题。我们最后就与使用kratom的人合作的最佳做法提出建议。